Cite

HARVARD Citation

    Pece, A. et al. (2012). Consensus on the diagnosis, treatment and follow-up of patients with age-related macular degeneration eligible for ranibizumab. Expert review of ophthalmology. pp. 219-225. [Online]. 
  
Back to record